Pharmaceuticals

Personalized Cancer Vaccines Market Trends and Insights: Global Forecast to 2030

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized cancer vaccines market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Personalized Cancer Vaccines Market be in 2030 compared with 2026?

The personalized cancer vaccines market has demonstrated significant expansion in recent years. Its valuation is anticipated to rise from $256.65 billion in 2025 to $273.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.4%. This past growth is largely attributable to progress in cancer genomics, the existing unmet need in oncology treatments, the constraints of conventional cancer therapies, the rise in immunotherapy research, and increased financial support for cancer research.

The personalized cancer vaccines market size is anticipated to experience robust growth in the upcoming years. It is projected to expand to $350.3 billion by 2030, achieving a compound annual growth rate (CAGR) of 6.4%. The expansion observed during the forecast period can be attributed to factors such as the increasing adoption of personalized medicine, rising cancer incidence rates, advancements in neoantigen discovery, growing collaboration among biotech firms, and supportive regulatory frameworks. Significant trends expected during this period include a heightened focus on personalized immunotherapy, increased application of genomic tumor profiling, the broadening of therapeutic cancer vaccines, greater integration with precision oncology, and a surge in clinical trial activity for cancer vaccines.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp

What Drivers Are Guiding Growth Patterns In The Personalized Cancer Vaccines Market?

The expanding occurrence of cancer is projected to fuel the growth of the personalized cancer vaccine market in the future. Cancer is defined as a collection of illnesses marked by unchecked cell proliferation, capable of infiltrating adjacent tissues and metastasizing throughout the body. The rising incidence of cancer is attributed to an aging global populace, shifts in lifestyle, exposure to environmental factors, and enhanced diagnostic tools. This market assists cancer treatment by offering vaccines customized to individual patient tumor antigens, thereby boosting the immune system’s capacity to recognize and eradicate cancerous cells. For example, in July 2024, the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, reported that cancer diagnoses in Australia escalated from 160,570 cases in 2022 to 164,694 cases in 2023, indicating a significant year-over-year increase. Consequently, the escalating prevalence of cancer is driving the expansion of the personalized cancer vaccine market.

How Is The Personalized Cancer Vaccines Market Divided Into Segments?

The personalized cancer vaccines market covered in this report is segmented –

1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma

3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action

4) By Route Of Administration: Injectables, Other Routes Of Administration

5) By End Use: Hospitals, Clinic, Other End Users

Subsegments:

1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines

2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines

Which Trends Are Expected To Influence The Personalized Cancer Vaccines Market In The Upcoming Years?

Major companies operating within the personalized cancer vaccine market are concentrating on creating advanced therapeutic solutions, such as personalized immunotherapy designed to target tumor mutations specific to individual patients, with the goal of improving treatment accuracy and enhancing clinical results. Personalized immunotherapy is defined as customized cancer treatments that utilize a patient’s unique genetic and tumor mutation profile, often administered through dendritic cell–based vaccines or neoantigen-targeted platforms, to activate a tailored immune response against malignant cells. For instance, in August 2024, UCLA Health, a US-based healthcare organization, initiated an unprecedented clinical trial assessing a personalized cancer vaccine that targets the H3 G34 mutation in diffuse hemispheric gliomas, employing dendritic cells to stimulate immunity against the RNA disruptions caused by this aggressive mutation, thereby presenting a promising therapeutic alternative for adolescents and young adults who typically face limited treatment choices and poor survival rates.

Which Major Firms Are Strengthening Their Position In The Personalized Cancer Vaccines Market?

Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Personalized Cancer Vaccines Market?

North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Cancer Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19136&type=smp

Browse Through More Reports Similar to the Global Personalized Cancer Vaccines Market 2026, By The Business Research Company

Therapeutic Bcg Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Cervical Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report

Dendritic Cell Cancer Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795